Efficacy and Safety of OMA102 in the Treatment of Female Pattern Hair Loss
ConditionFemale Pattern Baldness
Trial statusNot yet recruiting
Trial phasePhase 3
Trial typeInterventional
Biological sexFemale
Age18-50
SponsorEMS
About this trial
The goal of this clinical trial is to evaluate the efficacy and safety of OMA102 1 mg and OMA102 2 mg versus placebo in the treatment of female pattern hair loss.
Eligibility criteria
Qualifiers
Ability to confirm voluntary participation and agree to all trial purposes by signing and dating the informed consent forms;
Age greater than 18 and equal or under 50 years;
Confirmed diagnosis of female pattern hair loss, grade II to IV in Sinclair Scale;
Participants that are disposed to maintain the same hair color, style, approximate hair length throughout the Clinical Study.
Disqualifiers
Any clinical or physical finding interpreted by the investigator as a risk to subject participation in the Clinical Study
History of alcohol or illicit drugs abuse in the last year;
Pregnant or breastfeeding women, who are planning to become pregnant or participants who have childbearing potential and are not using any reliable contraceptive method;
Allergy or sensibility to any knowing components of the formula;
Trial design
Treatments tested in this trial
- OMA102
- OMA102
- Placebo
Treatment groups
504 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov